HAMILTON, Ontario, Jan. 07, 2021 — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company“), a rapidly growing digital health company that develops innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market has retained Lytham Partners, LLC (“Lytham Partners”) to lead a U.S. investor relations program.
For more than 20 years, Lytham Partners has been one of the industry’s leading investor relations firms in the U.S., having created one of the largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications.
“We made significant progress in 2020 in the United States by increasing our penetration beyond our historical markets of Florida and South Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “We are now working with clients across the U.S. and have a clear path to cashflow positive in Q1 2021. Given our recent progress and anticipated growth in 2021, we believe that this is an opportune time to increase awareness of our company within the U.S. investment community. We look forward to working with the team at Lytham Partners, which has a strong understanding of the healthcare technology space and a proven track record of helping public companies communicate their story to the largest and most relevant cross section of institutional investors.”
Ben Shamsian, Vice President of Lytham Partners, said, “Given Reliq’s fast growing and diversified customer base across the United States, we believe the U.S. investment community will be interested to learn more about their unique value proposition and opportunities ahead to create value for shareholders. We look forward to introducing the Company to our platform of investors while keeping shareholders apprised of the developments taking place at the Company.”
In connection with the engagement, Lytham Partners will be compensated USD $6,000 per month.
The Company also announces the granting of stock options under its Stock Option Plan to purchase an aggregate of 500,000 common shares of the Company at an exercise price of $0.415 per share for a five year term. The stock options were granted to the CFO of the Company pursuant to Reliq’s Stock Option Plan and the policies of the TSX Venture Exchange and vest over one year.
About Lytham Partners
For more than 20 years, Lytham Partners has been one of the country’s leading investor relations firms, having created one of the industry’s largest and most diverse networks of institutional investors, while creating a framework of best practices in all aspects of corporate and shareholder communications. In addition to their relationships with many of the industry’s most respected institutional investors, Lytham Partners has spent the past two decades creating an integrated platform that allows its clients far reaching exposure to investors in a consistent and in-depth format. This platform is matched with a communications and positioning approach that is streamlined throughout press releases, conference calls, investor presentations, corporate profiles, and websites. For more information visit our website at www.lythampartners.com.
About Reliq Health
Reliq Health Technologies is a rapidly growing digital health company that specializes in developing innovative Virtual Care software as a service (SaaS) solutions for the Community Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTCQB as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company Contact
Investor Relations at ir@reliqhealth.com
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
Telephone: 646-829-9701
shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
